Animal models for Pneumocystis carinii, for the most part, have been limited to immunosuppressed rats and ferrets, while a dependable mouse model has been more difficult to develop. A P. carinii mouse model has now been established with several strains of mice, including C3Heb/FeJ, C3HeN, BALB/c, DBA12N, and BALB/c nu/nu (athymic). In lieu of using invasive methods for initiating P. carinii infections, mice harboring P. carinii transmitted the disease to mice without latent infection via short-term cohabitation. After the exposure period, the seed mice were sacrificed to confirm the presence of acute P. carinii pneumonia. Acute infections in recipient mice developed at approximately 7 to 8 weeks, while control unseeded littermates remained uninfected. All recipient mice and their littermates were maintained in isolation hoods to eliminate the possibility of exposure to other sources of P. carinii. This approach allows investigators to consistently transmit P. carinii to mice and to select the strain of mouse desired for use in a particular study. The results presented here suggest that more attention should be given to the potential for patient-to-patient transmission of P. carinii in immunocompromised patients such as those with AIDS.
Pneumocystis carinii pneumonia is one of the major lifethreatening illnesses in AIDS patients. The causative agent, P. carinii, is an opportunistic pathogen which develops in the lungs of immunocompromised patients. Because of the high incidence of adverse reactions in AIDS patients to the currently available antipneumocystis agents, there is an urgent need for a new class of drugs which is safe and effective. Since the organism has not been successfully propagated in vitro, investigators have been restricted, for the most part, to in vivo models for evaluation of candidate compounds. The standard animal models utilize rats and ferrets. P. carinii pneumonia has been shown to occur in immunosuppressed mice (15) and genetically immunodeficient athymic (nu/nu) and severe combined immune deficient (SCID) mice (5, 8, 11, 13, 14, 17) . However, in mice which develop P. carinii pneumonia, either as a result of congenic immunodeficiencies or immunosuppression, the infections are variable. Development of infection in athymic and SCID mice is slow and not always predictable because these mice develop P. carinii pneumonia naturally as they age.
Host susceptibility and as yet undefined immune responses to P. carinii could be more efficiently studied by using mice. Congenic inbred mice are well characterized both genetically and immunologically and many strains differing in specific genetic characteristics are currently available. In addition, when chemotherapeutic studies are conducted, smaller amounts of compound would be required for mice when potential antipneumocystis agents are evaluated (compared, for example, with rats). The focus of this study was to identify a source of mice with latent P. carinii and to explore whether these mice could be used to selectively infect other mouse strains through cohabitation. It has been known for some time that P. carinii is transmitted via the air and that P. carinii-free animals can become infected when kept near infected animals (6 Figure legends give the specific parameters of each experiment.
P. carinii transmission. P. carinii was transmitted to recipient mice by cohabitation with infected C3Heb/FeJ seed mice that were previously immunosuppressed for 5 to 8 weeks prior to use. Two seed mice were placed with 10 to 15 recipient mice and were allowed to cohabitate for 1 to 2 weeks. Recipient and seed mice continued to receive dexamethasone for the duration of the experiment. The seed mice were 12 to 14 weeks of age, and the recipient mice were 7 to 9 weeks of age; however, since the seed mice had been receiving dexamethasone, which suppresses weight gain in mice, there was not a significant difference in the size of the animals during cohabitation. Transmission studies were conducted within laminar air flow isolation hoods. Unseeded control groups were immunosuppressed and placed in separate hoods to prevent exposure to seeded mice. Seed mice were sacrificed after the seeding period, and P. carinii infection was confirmed by toluidine blue staining of cysts (see below).
Evaluation of lung tissue. Excised lungs were homogenized in 5.0 ml of phosphate-buffered saline (Sigma Chemical Co., St. Louis, Mo.) with a homogenizer (Brinkmann Instruments, Inc., Westbury, N.Y.) at speed 3 for approximately 5 s. Homogenates were centrifuged (Beckman GPR centrifuge) at 1,700 x g for ten minutes. The erythrocytes were lysed by resuspending the pellet in 5.0 ml of a 0.85% ammonium chloride (Mallinckrodt, Paris, Ky.) solution, incubating the suspension for 5 min in a 37°C water bath, and then centrifuging the suspension at 1,700 x g (10 min). The pellets were washed once in saline, and the final pellets were resuspended in 100 ,ul of saline. A 5.0-pl aliquot of each sample was evenly applied and air-dried onto Teflon-coated microscope slides with a fixed surface area (11-mm circles; Carlson Scientific, Peotone, Ill.). The extent of disease for each animal was determined by microscopic analysis of stained slides. The total number of cysts per animal lung was determined by quantitating the number of cysts in 20 to 50 microscope fields (1,OOOx) of homogenized lung tissue on slides fixed with ether-sulfuric acid and stained with toluidine blue 0 (2). The total number of organisms per mouse lung was determined as a function of the surface area on the slide, the volume of the applied sample, and the total volume of the processed homogenate.
RESULTS
Identification of mice with latent P. carinii. A survey of several mouse strains from various sources was performed by using an immunosuppression regimen of 8 mg of dexamethasone per liter in the drinking water (ad libitum) and an 8% protein diet for 6 weeks. Mouse strain C3Heb/FeJ was identified as having a latent P. carinii infection (data not shown).
Establishment of conditions for an optimal P. carinii infection. When C3Heb/FeJ mice were maintained on an 8% protein diet, it was found that the optimal dose of dexamethasone required to achieve an acute P. carinii infection in 6 to 8 weeks was 4 mg/liter (Fig. 1) . Mice maintained on an 8% protein diet alone were mildly infected with P. carindi ( Fig. 1, 0 mg/liter). To evaluate the independent effect of dexamethasone, mice were immunosuppressed while receiving 23% protein rodent chow (Fig. 2) significantly enhance the infection and the 2-mg/liter level produced suboptimal infection.
Although an 8% protein diet did contribute to the level of infection at the 1-and 2-mg/liter levels, as seen in Fig. 1 and 2, the degree of P. carinii infection at the 4-mg/liter level was comparable for the 23 and the 8% protein diet. As a result, the 8% protein diet was eliminated from use in subsequent experiments.
Levels of dexamethasone greater than 4 mg/liter increased the incidence of mortality in both steroid titrations. There was no mortality observed in mice administered 0, 2, and 4 mg of dexamethasone per liter in the 23% protein rodent chow steroid titration; however, a 13.3% mortality was found in mice administered 8 mg of dexamethasone per liter. (Mortality was also observed in mice who received 8 mg of dexamethasone per liter and were maintained on the 8% protein diet, but it was not documented.)
Transmission ofP. carinii to other immunosuppressed mice. P. carinii was successfully transmitted from infected C3Heb/ FeJ mice to recipient C3HeN mice during a single week of cohabitation. After cohabitating, recipient mice remained on 6 (Fig. 2) . A 2-mg/liter level of dexamethasone was also tested with BALB/c mice, and infections were comparable to those seen at the 4-mg/liter level (data not shown). Control mice, which had not been exposed to seed mice, did not develop P. carinii infections, indicating that the experimental recipient animals were free of P. carinii prior to exposure to seed mice.
Time course study of BALB/c recipient mice. A time course study of BALB/c recipient mice (Fig. 3) shows gradual development of P. carinii infection after seeding. The infection was similar to that seen in C3Heb/FeJ mice (Fig. 2) (Times include a 2-week cohabitation period.) All points represent five animals. The detection limit is 3.36 cysts per lung (log1o). 4 .58 + 0.38 and 5.62 cysts per lung, respectively (limit of detection, 3.36 cysts per lung).
Successful transmission of P. carinii to SCID mice was also performed. Recipient SCID mice that were sacrificed 5 weeks after cohabitation showed P. carinii cysts (4.38 + 0.15 cysts per lung; limit of detection, 3.36 cysts per lung) while control unseeded SCID mice were all negative for P. carinii. Unfortunately, none of the mice in either the control or the seeded groups survived to 7 weeks postcohabitation. Presumably these mice died as a result of secondary infections due to their severely compromised immune state and their exposure to seed mice which were not caesarean derived and kept under sterile conditions.
DISCUSSION
The experiments reported here demonstrate that P. cannii infections can be successfully established in several strains of mice by short-term cohabitation with previously infected mice. This eliminates the need for invasive methods to infect mice with P. carinii (1) , as well as the requirement for a viable source of cryopreserved organisms, which must be derived from infected animals. In addition to allowing for the development of P. carinii in a chosen strain of mouse, this method should also be useful for the continuous propagation of P. carinii infection within a colony of immunosuppressed mice. By utilizing recipient mice with developed P. cannii infections to seed subsequent groups of immunosuppressed mice, one is able to maintain established infection indefinitely. This eliminates dependence on an animal supplier with a consistent source of mice possessing latent P. carinii. Also, mice used for seeding can still be used for studies after the cohabitation period, allowing for more efficient animal usage.
The (14) . These experiments suggest that it is possible to establish a more consistent infection by transmitting P. carinii through cohabitation. As a result, the source of the P. cannii appearing in older athymic mouse colonies must be questioned. A latent infection would be expected to be established sooner, so athymic immunodeficient mice may be exposed to P. carinii at some point as they age. The sample size in this experiment was small because of incompatibility of the C3Heb/FeJ mice and the athymic (nu/nu) mice. Most of the seeds were not able to survive the 2-week seed period. However, it is evident from the results that transmission did occur by this method.
The relationship between development of infection in mice with latent P. carinii and seeded mice can be examined at the C3Heb/FeJ 4-mg/liter steroid level (Fig. 2 ) and in the BALB/c time course study (Fig. 3 ). While mice with latent infections had an increased level of P. cannii cysts initially, the seeded animals were only 1 week behind the latently infected animals in developing P. carinii pneumonia by week 6. Since the BALB/c time points include the seed period, this substantiates the claim that transmission occurs in a 1-week seed period. The time course study also demonstrates the uniform infection level seen in the recipient mice at different times (see standard errors), a major improvement over claims in the literature of widely variable P. cannii infections within groups of immunosuppressed mice (16) . The levels of dexamethasone used in these experiments have been optimized for C3Heb/FeJ mice, and different levels may be optimal for other types of mice. Many of the strains used in these studies were not able to tolerate 8 mg of dexamethasone per liter, while the C3Heb/FeJ mice did. Also, the BALB/c mice developed comparable levels of infection whether on 4 or 2 mg of dexamethasone per liter. Optimization for a particular mouse strain should be investigated before a dexamethasone level is used routinely. Since water consumption was not determined for these experiments, it is possible that the various mouse strains differ in the amount of water they consume.
These cohabitation experiments support claims that human transmission of P. carini between immunocompromised individuals in the clinical setting is likely to occur (3, 4, 6, 7, 9, 10, 12) . Although P. carinii is considered endemic, the results of the initial seeding study indicate that seed mice not immunosuppressed prior to cohabitation are able to transmit infection at low levels. This suggests that the level of initial exposure to P. cannii has a major bearing on the rate at which an infection is established. A closer look at the epidemiology of P. carinii in the hospital setting is warranted.
